FI853283L - Nya monoklonala antikroppar mot glykokonjugat, foerfaranden foer framstaellning av desamma, och deras anvaendningar. - Google Patents

Nya monoklonala antikroppar mot glykokonjugat, foerfaranden foer framstaellning av desamma, och deras anvaendningar.

Info

Publication number
FI853283L
FI853283L FI853283A FI853283A FI853283L FI 853283 L FI853283 L FI 853283L FI 853283 A FI853283 A FI 853283A FI 853283 A FI853283 A FI 853283A FI 853283 L FI853283 L FI 853283L
Authority
FI
Finland
Prior art keywords
glycokonjugat
anvaendningar
desamma
nya
foer framstaellning
Prior art date
Application number
FI853283A
Other languages
English (en)
Finnish (fi)
Other versions
FI853283A0 (fi
Inventor
Guenter Rosenfelder
Harry Towbin
Dietmar Braun
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848421944A external-priority patent/GB8421944D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI853283A0 publication Critical patent/FI853283A0/fi
Publication of FI853283L publication Critical patent/FI853283L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI853283A 1984-08-30 1985-08-28 Nya monoklonala antikroppar mot glykokonjugat, foerfaranden foer framstaellning av desamma, och deras anvaendningar. FI853283L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848421944A GB8421944D0 (en) 1984-08-30 1984-08-30 Monoclonal antibodies
GB858515538A GB8515538D0 (en) 1984-08-30 1985-06-19 Monoclonal antibodies

Publications (2)

Publication Number Publication Date
FI853283A0 FI853283A0 (fi) 1985-08-28
FI853283L true FI853283L (fi) 1986-03-01

Family

ID=26288164

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853283A FI853283L (fi) 1984-08-30 1985-08-28 Nya monoklonala antikroppar mot glykokonjugat, foerfaranden foer framstaellning av desamma, och deras anvaendningar.

Country Status (11)

Country Link
EP (1) EP0173648A3 (es)
AU (1) AU4688785A (es)
DK (1) DK391785A (es)
ES (2) ES8703895A1 (es)
FI (1) FI853283L (es)
GR (1) GR852099B (es)
HU (1) HUT38391A (es)
IL (1) IL76247A0 (es)
NO (1) NO853397L (es)
NZ (1) NZ213293A (es)
PT (1) PT81040B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202252A (en) * 1982-03-05 1993-04-13 Houston Biotechnology Inc. Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
US5055291A (en) * 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
FI95203C (fi) * 1986-11-04 1996-01-10 Baylor College Medicine Analogiamenetelmä sytotoksisen koostumuksen valmistamiseksi
US5616122A (en) * 1986-11-04 1997-04-01 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US5104652A (en) * 1986-11-13 1992-04-14 Sloan-Kettering Institute For Cancer Research Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2
ES2053704T3 (es) * 1987-02-20 1994-08-01 Akzo Nv Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
WO1989002599A1 (en) * 1987-09-08 1989-03-23 The Biomembrane Institute Detection of survived, undegraded carbohydrate epitopes as diagnostic of intestinal diseases
US5030723A (en) * 1988-05-31 1991-07-09 The Biomembrane Institute Long-chain glycolipid structure
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
AU781171B2 (en) * 1997-06-10 2005-05-12 Lpath Therapeutics, Inc. Methods for early detection of heart disease
CA2432978C (en) * 2000-12-22 2012-08-28 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US20080138334A1 (en) 2006-05-31 2008-06-12 Sabbadini Roger A Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US8796429B2 (en) 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
JP5732182B2 (ja) 2006-10-27 2015-06-10 エルパス・インコーポレイテッドＬｐａｔｈ， Ｉｎｃ． 眼疾患と症状を処置するための組成物および方法
PL2087002T3 (pl) 2006-10-27 2015-02-27 Lpath Inc Kompozycje i sposoby do wiązania sfingozyno-1 fosforanu
US8361465B2 (en) * 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
EP0209493A3 (en) * 1985-07-16 1988-05-04 Ciba-Geigy Ag Prophylaxis and treatment of whooping cough

Also Published As

Publication number Publication date
IL76247A0 (en) 1986-01-31
NZ213293A (en) 1988-11-29
DK391785A (da) 1986-03-01
DK391785D0 (da) 1985-08-29
AU4688785A (en) 1986-03-06
EP0173648A3 (en) 1988-04-27
ES8703895A1 (es) 1987-03-01
GR852099B (es) 1986-01-02
HUT38391A (en) 1986-05-28
PT81040B (en) 1987-06-24
ES8800845A1 (es) 1987-12-01
NO853397L (no) 1986-03-03
ES546564A0 (es) 1987-03-01
ES555613A0 (es) 1987-12-01
FI853283A0 (fi) 1985-08-28
EP0173648A2 (en) 1986-03-05
PT81040A (en) 1985-09-01

Similar Documents

Publication Publication Date Title
FI853443A0 (fi) Nya anvaendningssystem foer soetningsmedel och foerfarande foer framstaellning av dessa.
FI853537A0 (fi) Nya soetningsmedelssystem innehaollande tuggummikompositioner och foerfarande foer deras framstaellning.
FI80883B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensotiazol- och bensotiofenderivat.
FI853283L (fi) Nya monoklonala antikroppar mot glykokonjugat, foerfaranden foer framstaellning av desamma, och deras anvaendningar.
FI850429A0 (fi) Nya renin-inhiberande peptider och deras anvaendning.
FI840968A (fi) Nya azoler, deras framstaellningsprocesser och deras anvaendning.
FI845117A0 (fi) Nya fenyl-imidazoler, deras framstaellning och dessa foereningar innehaollande laekemdel.
FI852796L (fi) Nya pyrimidinderivat, foerfarande foer deras framstaellning och dessa innehaollande kompositioner.
FI855080A (fi) Nya imidazoderivat, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI842666A0 (fi) Nya imidazoler, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI843672L (fi) Nya pyridoindolderivat, deras framstaellningsfoerfarande och deras anvaendning.
FI855081A (fi) Nya imidazoderivat, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI840675A (fi) Nya immunoglobulin producerande hybridcelllinjer, deras anvaendning och foerfarande foer deras framstaellning.
FI841594A0 (fi) Nya fenylalkansyraderivat, deras framstaellning och anvaendning.
FI862206A0 (fi) Anordning foer fasthaollning, akustisk taetning och vibrationsisolering av en elektroakustisk omvandlare.
FI845084A0 (fi) Nya benzimidazoler, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI854863A0 (fi) Nya imidazoderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI845086L (fi) Nya imidazolderivat, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI853651L (fi) Nya hydroxitiaalkener, deras framstaellning och anvaendning.
FI844480A0 (fi) Nya azabicykliska foereningar och foerfarande foer deras framstaellning.
FI851612L (fi) Nya apovinkaminolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI842884A0 (fi) Nya tioamider, deras framstaellning och anvaendning.
FI854707A0 (fi) Nya piperazinderivat, foerfarande foer framstaellning och andvaendning av desamma.
FI842853A (fi) Nya 1-fenylimidazolidin-2-on-derivat, deras framstaellning och anvaendning.
FI854745A0 (fi) Nya sulfamoylbensoesyraderivater och foerfarande foer deras framstaellning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: CIBA-GEIGY AG